Fundz

Bond Biosciences

Parkville, Missouri, United States · Biotechnology, Healthcare, Health Care

Bond Biosciences, Inc. is a privately held, clinical stage biopharmaceutical company focused on the discovery and development of first-in-class non-absorbed oral therapeutics that bind excess ions locally in the gastrointestinal (GI) tract to treat or prevent human disease.

Key facts

Headquarters
Parkville, Missouri, United States
Employees
3
Industries
Biotechnology, Healthcare, Health Care
Status
Private
Website
bond.bio
LinkedIn
Company page

Recent activity at Bond Biosciences

Bond Biosciences funding history

DateRoundAmount
Jun 2026Venture$5.9M
Sep 2024Seed$2.6M
Jan 2022Venture$6.8M
Nov 2020Venture$3.1M
Sep 2020Venture$4.5M

Leadership

  • Danny Griffin, Director of Business Development
  • Cory Berkland, Director
  • Michael Riley, Executive Officer, Director
  • Timothy Opler, Director

Verified email and direct lines for Bond Biosciences’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Bond Biosciences in the news

Companies similar to Bond Biosciences

About Bond Biosciences: questions and answers

What does Bond Biosciences do?

Bond Biosciences, Inc. is a privately held, clinical stage biopharmaceutical company focused on the discovery and development of first-in-class non-absorbed oral therapeutics that bind excess ions locally in the gastrointestinal (GI) tract to treat or prevent human disease.

Where is Bond Biosciences headquartered?

Bond Biosciences is headquartered in Parkville, Missouri, United States.

How many employees does Bond Biosciences have?

Bond Biosciences has about 3 employees.

Has Bond Biosciences raised funding?

Yes. Fundz has recorded 5 funding events for Bond Biosciences. The most recent, $5.9M, was in Jun 2026.

What is the latest news on Bond Biosciences?

On Jun 04, 2026, Bond Biosciences

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Bond Biosciences across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.